Acadia Healthcare Company, Inc. $ACHC Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. trimmed its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 9,350,959 shares of the company’s stock after selling 66,086 shares during the period. Vanguard Group Inc. owned 10.14% of Acadia Healthcare worth $132,690,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Principal Financial Group Inc. raised its stake in shares of Acadia Healthcare by 112.1% in the 3rd quarter. Principal Financial Group Inc. now owns 442,943 shares of the company’s stock valued at $10,967,000 after acquiring an additional 234,107 shares during the period. Invenomic Capital Management LP increased its position in shares of Acadia Healthcare by 41.6% during the third quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company’s stock worth $47,945,000 after acquiring an additional 568,796 shares during the last quarter. Public Sector Pension Investment Board purchased a new position in Acadia Healthcare in the third quarter valued at about $8,919,000. First Citizens Bank & Trust Co. raised its holdings in Acadia Healthcare by 164.1% in the third quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company’s stock valued at $1,464,000 after acquiring an additional 36,733 shares in the last quarter. Finally, Citigroup Inc. raised its stake in Acadia Healthcare by 7.6% during the third quarter. Citigroup Inc. now owns 793,596 shares of the company’s stock valued at $19,649,000 after buying an additional 56,109 shares in the last quarter.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. UBS Group raised their price target on Acadia Healthcare from $27.00 to $31.00 and gave the stock a “buy” rating in a report on Friday, April 17th. Jefferies Financial Group reiterated a “hold” rating and issued a $24.50 target price on shares of Acadia Healthcare in a research note on Monday, April 20th. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target for the company in a report on Monday, May 4th. Cantor Fitzgerald increased their price objective on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. Finally, TD Cowen lifted their price objective on shares of Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a research report on Tuesday, April 28th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $26.04.

Acadia Healthcare Stock Down 0.7%

ACHC stock opened at $25.01 on Tuesday. The firm has a market cap of $2.30 billion, a PE ratio of -2.04, a P/E/G ratio of 8.44 and a beta of 0.73. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $30.20. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The firm has a 50 day simple moving average of $25.05 and a 200 day simple moving average of $19.15.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. During the same quarter in the prior year, the company earned $0.40 earnings per share. The firm’s revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.49 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.